Mursla Revenue and Competitors
Estimated Revenue & Valuation
- Mursla's estimated annual revenue is currently $2.5M per year.
- Mursla's estimated revenue per employee is $155,000
Employee Data
- Mursla has 16 Employees.
- Mursla grew their employee count by -11% last year.
Mursla's People
Name | Title | Email/Phone |
---|---|---|
1 | Scientist | Reveal Email/Phone |
Mursla Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Mursla?
Mursla is Cambridge-based startup developing a novel tech platform to trace tumours early in the blood via the discovery and quantification of cancer-specific exosome subpopulations.
keywords:N/AN/A
Total Funding
16
Number of Employees
$2.5M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Mursla News
2022-04-13 - Murslas nanochip technology for exosome detection poised to transform
disease diagnosis
Pierre Arsène, founder and CEO of Mursla, said: We believe that properly analysing exosome biology in patients leads to breakthrough diagnostic...
2022-04-06 - Mursla Unveils Novel Bead-Nanochip Technology for ...
This technology is part of Mursla's ExoPheno platform. We believe that properly analysing exosome biology in patients leads to breakthrough...
2022-03-22 - Mursla gains mentorship support from Roche Diagnostics Ltd ...
Mursla gains mentorship support from Roche Diagnostics Ltd for pilot study in cirrhotic and liver cancer patients. 30-03-2022. Access to Roche Diagnostics'...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.8M | 16 | -6% | N/A |
#2 | $2.5M | 16 | 7% | N/A |
#3 | $1.2M | 16 | -11% | $65M |
#4 | $1.2M | 16 | -6% | $59M |
#5 | $1.9M | 16 | 0% | N/A |